Immatics NV (IMTX)
6.52
-0.17
(-2.54%)
USD |
NASDAQ |
Nov 12, 16:00
6.51
-0.01
(-0.15%)
After-Hours: 20:00
Immatics Shareholders Equity (Quarterly) : 498.07M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 498.07M |
| June 30, 2026 | 456.89M |
| March 31, 2026 | 525.17M |
| December 31, 2025 | 568.55M |
| September 30, 2025 | 489.60M |
| June 30, 2025 | 545.34M |
| March 31, 2025 | 579.64M |
| December 31, 2024 | 595.25M |
| September 30, 2024 | 426.92M |
| June 30, 2024 | 415.72M |
| March 31, 2024 | 432.85M |
| December 31, 2023 | 248.64M |
| September 30, 2023 | 262.31M |
| June 30, 2023 | 238.07M |
| Date | Value |
|---|---|
| March 31, 2023 | 217.38M |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | 130.62M |
| March 31, 2022 | 129.05M |
| December 31, 2021 | 27.36M |
| September 30, 2021 | 40.75M |
| June 30, 2021 | 90.65M |
| March 31, 2021 | 110.11M |
| December 31, 2020 | 106.92M |
| September 30, 2020 | 142.66M |
| June 30, 2020 | -76.93M |
| March 31, 2020 | -55.76M |
| December 31, 2019 | -46.98M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| BioNTech SE | 20.12B |
| MediGene AG | -- |
| InflaRx NV | 163.68M |
| Twist Bioscience Corp. | -- |
| Prime Medicine, Inc. | 39.81M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 642.58M |
| Total Liabilities (Quarterly) | 144.51M |
| Debt to Equity Ratio | 0.1079 |
| Current Ratio | 5.025 |
| Net Debt Paydown Yield | -0.50% |